共 119 条
[1]
Anil G(2011)Thyroid nodules: risk stratification for malignancy with ultrasound and guided biopsy Cancer Imaging 11 209-223
[2]
Hegde A(2021)The Bethesda System for Reporting Thyroid Cytopathology: a meta-analysis Acta Cytol 56 333-339
[3]
Chong FH(2012)Yield of repeat fine-needle aspiration biopsy and rate of malignancy in patients with atypia or follicular lesion of undetermined significance: the impact of the Bethesda System for reporting thyroid cytopathology Surgery 152 1037-1044
[4]
Bongiovanni M(2009)The Bethesda System for reporting thyroid cytopathology Am J Clin Pathol 132 658-665
[5]
Spitale A(2009)The Bethesda System for reporting thyroid cytopathology Thyroid 19 1159-1165
[6]
Faquin WC(2019)Comparison among TIRADS (ACR TI-RADS and KWAK- TI-RADS) and 2015 ATA Guidelines in the diagnostic efficiency of thyroid nodules Endocrine 64 90-96
[7]
Mazzucchelli L(2019)Malignancy risk of initially benign thyroid nodules: validation with various Thyroid Imaging Reporting and Data System guidelines Eur Radiol 29 133-140
[8]
Baloch ZW(2016)2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer Thyroid 26 1-133
[9]
Chen JC(2014)Malignancy rate in thyroid nodules classified as Bethesda Category III (AUS/FLUS): is there a correct answer? Thyroid 24 787-788
[10]
Pace SC(2018)Impact of the modification of the diagnostic criteria in the 2017 Bethesda System for reporting thyroid cytopathology: a report of a single institution in Japan Endocr J 65 1193-1198